Vanguard Capital Management
IRMD icon

Vanguard Capital Management’s iRadimed IRMD Stock Holding History

Vanguard Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.9M Buy
364,937
+6,317
+2% +$575K ﹤0.01% 2133
2026
Q1 		$34.5M Buy
+358,620
New +$35.9M ﹤0.01% 2053

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management's IRMD Position: Q2 2026 in Review

Vanguard Capital Management increased its iRadimed (IRMD) stake by 1.8% in Q2 2026, buying an estimated $575K and bringing the position to 364,937 shares worth $34.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2133.

Vanguard Capital Management first reported a position in IRMD in Q1 2026 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Vanguard Capital Management held 364,937 shares of iRadimed worth $34.9M as of Q2 2026.
  • Vanguard Capital Management bought 6,317 iRadimed shares in Q2 2026, an estimated $575K.
  • iRadimed made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2133 holding.
  • Vanguard Capital Management first reported a position in iRadimed in Q1 2026 and has held it in 2 quarters since.
  • 212 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.